|
Company will design, manufacture and market devices aimed at lowering the total cost of genetic sequencing.
Chicopee, Mass., - Innovative Microplate, Inc., a privately held company based in Chicopee, Mass., has been awarded a contract for the joint development, manufacture and marketing of novel devices for genetic sequencing. The multi-year contract, from the Genome Therapeutics’ business unit GenomeVision™ Services, involves the development of advanced manufacturing and assembly automation techniques and full-scale production of the devices.
Peter A. Hunter, CEO of Innovative Microplate said, “Being chosen by Genome Therapeutics to jointly develop, manufacture and market devices to help lower the cost of sequencing is a clear validation of the quality Innovative Microplate is able to deliver to its many customers."
About Innovative Microplate
Innovative Microplate – is a leading supplier of high quality application specific microplates, filter plates and other storage devices to the biopharmaceutical industry. Innovative Microplate has developed an unprecedented capability to meet the exceptional time-to-market demands of its customers with its proprietary design and production resources.
| 
